Retatrutide 10mg

Retatrutide 10mg – High-Purity Research Peptide

Retatrutide is a next-generation investigational peptide designed to act as a triple receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This unique triagonist activity positions Retatrutide as a highly promising compound in the field of metabolic research.

Retatrutide 10mg, Originally developed for its potential in addressing obesity, type 2 diabetes, and related metabolic disorders, Retatrutide has shown significant preclinical potential in enhancing glucose tolerance, promoting fat loss, and regulating appetite. Its mechanism involves synergistically activating key hormonal pathways that influence energy balance, insulin secretion, and satiety.

Product Features:

• Peptide Name: Retatrutide (LY3437943)

• Concentration: 10mg per vial

• Form: Lyophilized white/off-white powder

• Purity: ≥98% (HPLC-tested)

• Molecular Formula: C₁₉₀H₂₉₁N₅₅O₅₇

• Molecular Weight: ~4,940 Da

• Storage Guidelines:

  • Long-term storage at -20°C

  • Protect from light and moisture

  • Reconstituted solutions should be stored at 2–8°C and used within a limited timeframe.

Research Applications:

Retatrutide is currently being studied in preclinical and early clinical models for its ability to:

• Improve glycemic control

• Reduce body weight and fat mass

• Suppress appetite and food intake

• Enhance energy expenditure

• Offer potential in treating obesity, insulin resistance, and type 2 diabetes

Quality Assurance.